Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-011438
Filing Date
2020-04-28
Accepted
2020-04-28 16:57:17
Documents
2
Period of Report
2020-04-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2739
2 EX-24 DOCUMENT attachment1.htm EX-24 4202
  Complete submission text file 0000899243-20-011438.txt   8212
Mailing Address
Business Address
COUGHLIN CHRISTOPHER J (Reporting) CIK: 0001110750 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38958 | Film No.: 20825870

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations